History
  • No items yet
midpage
Sorrell v. IMS Health Inc.
564 U.S. 552
SCOTUS
2011
Read the full case

Background

  • Vermont enacted Act 80, including § 4631(d), prohibiting sale, disclosure, or use of prescriber-identifiable information for marketing absent prescriber consent, with narrowly drawn exceptions.
  • Prescriber-identifying data are generated through prescription processing and are sold by data miners to pharmaceutical manufacturers to tailor marketing (detailers).
  • Detailing involves in-person visits to doctors with drug information; knowledge of prescribing practices helps target messages to physicians, especially for brand-name drugs.
  • The law targets manufacturers and marketers by restricting their use of prescriber data for marketing, while allowing others (researchers, insurers, etc.) to use the data for non-marketing purposes under exceptions.
  • Two consolidated suits were brought by Vermont data miners and a pharmaceutical manufacturers’ association; district court denied relief, and the Second Circuit reversed, ruling § 4631(d) violated the First Amendment. Supreme Court granted certiorari.
  • The majority preserves the case’s First Amendment questions by evaluating § 4631(d) as content- and speaker-based restraints in a regulatory context.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Is § 4631(d) a content- and speaker-based restriction on speech? Manufacturers argue the law targets messaging to physicians and penalizes a class of speakers (detailers). The State contends it is a permissible commercial-regulation measure restricting use of data for marketing. Yes; burdens are content- and speaker-based and trigger heightened scrutiny.
Does § 4631(d) fail Central Hudson’s test for commercial speech? The data-restriction aims to limit persuasive marketing and thus requires substantial justification. Regulation is neutral with respect to messages and serves public health/privacy interests. Yes; the statute does not satisfy Central Hudson’s fit between ends and means.
Do Vermont’s asserted privacy and public-health goals justify the content- and speaker-based burdens? Privacy and anti-harassment protections justify restricting disclosure and use of data for marketing. Regulatory privacy is insufficient to sustain a broad content- and speaker-based ban; alternatives exist. No; the burdens are not sufficiently tailored to achieve the interests.
Could a more limited restriction (narrower sale/disclosure allowances) be constitutionally permissible? A narrower regime focusing on the least-restrictive means could satisfy interests. The current framework includes narrow exceptions and does not demonstrate an equally effective alternative. Not enough to save the statute; the challenged provisions fail First Amendment scrutiny.

Key Cases Cited

  • Central Hudson Gas & Electric Corp. v. Public Serv. Comm’n of N. Y., 447 U.S. 557 (Supreme Court 1980) (intermediate scrutiny for lawful regulation of commercial speech)
  • Virginia Bd. of Pharmacy v. Virginia Citizens Consumer Council, Inc., 425 U.S. 748 (Supreme Court 1976) (unbiased information and consumer protection in commercial speech)
  • R. A. V. v. City of St. Paul, 505 U.S. 377 (Supreme Court 1992) (content-based restrictions presumptively invalid)
  • Cincinnati v. Discovery Network, Inc., 507 U.S. 410 (Supreme Court 1993) (government can regulate commercial speech with intermediate scrutiny)
  • United States v. O’Brien, 391 U.S. 367 (Supreme Court 1968) (regulation of symbolic speech; test for governmental regulation of expressive conduct)
  • Los Angeles Police Dept. v. United Reporting Publishing Corp., 528 U.S. 32 (Supreme Court 1999) (facial challenges to access-to-information regimes; difference between government-held vs private information)
Read the full case

Case Details

Case Name: Sorrell v. IMS Health Inc.
Court Name: Supreme Court of the United States
Date Published: Jun 23, 2011
Citation: 564 U.S. 552
Docket Number: No. 10-779
Court Abbreviation: SCOTUS